Repligen (RGEN) Cost of Revenue (2010 - 2026)

Repligen (RGEN) has reported Cost of Revenue for 17 consecutive years, with $94.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 5.28% year-over-year to $94.1 million in Q2 2026; TTM through Jun 2026 was $362.4 million, a 2.9% decrease from a year earlier, with the FY2025 full-year figure at $352.0 million, down 2.16% from the prior year.
• Cost of Revenue was $94.1 million for Q2 2026 at Repligen, up from $86.0 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $128.7 million in Q4 2024 and troughed at $76.4 million in Q1 2024.
• A 5-year average of $88.3 million and a median of $86.4 million in 2022 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue soared 46.03% in 2024 and declined 26.9% in 2025, its largest moves.
• Over 5 years, Cost of Revenue stood at $90.7 million in 2022, then slipped by 2.83% to $88.1 million in 2023, then soared by 46.03% to $128.7 million in 2024, then decreased by 26.9% to $94.1 million in 2025, then rose by 0.01% to $94.1 million in 2026.
• The last three Cost of Revenue figures came in at $94.1 million (Q2 2026), $86.0 million (Q1 2026), and $94.1 million (Q4 2025), per Business Quant data.